Jupiter Stock Soars After $100 Million ALA-002 Licensing Deal - Jupiter Neurosciences (NASDAQ:JUNS)

Jupiter Neurosciences shares are rising Wednesday after it announced the acquisition of US licensing rights to ALA-002 from Pharmala Biotech.

Raccontata dabenzinga.com